Benzinga | Nov 9, 2020 03:45PM EST

Immutep Shares Spike To Session High; Traders Circulate Purported Company Press Release Showing Favorable Response Rates In Phase II TACTI-002 Study Of IMP321 And Keytruda For Cancer

https://www.docdroid.net/NTkEj4K/immp-sitc-pdf